Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (Fv-IgG) (BSDG-013)

Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-B cell lymphoma 38C13 Idiotype IgG with similar domains from an anti-CD44 antibody via short peptide linkers, or vice versa. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy.

Datasheet INQUIRY

Specifications

Targets

B cell lymphoma 38C13 Idiotype & CD44

Type

Appended IgGs

Species Reactivity

Mouse

Application

FuncS; Promising therapeutic agent

Related Disease

B cell lymphoma

Targets

Target 1

B cell lymphoma 38C13 Idiotype

Alternative Names

B cell lymphoma 38C13 Idiotype; B cell lymphoma; 38C13; Idiotype; Id

Target 2

CD44

Gene ID

12505

UniProt ID

P15379

Alternative Names

CD44; CD44 antigen; ECMRIII; Extracellular matrix receptor III; HCAM; Homing cell adhesion molecule; Pgp-1; phagocytic glycoprotein-1; HUTCH-1; Ly-24; Pgp-1; HERMES; AU023126; AW121933; AW146109

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "B cell lymphoma 38C13 Idiotype & CD44"

See other bsAb targets related to "B cell lymphoma 38C13 Idiotype"

See other bsAb targets related to "CD44"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (Fv-IgG) (BSDG-013). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (Fv-IgG) (CAT#: BSDG-013)

Specifications

Targets

Customer Reviews and Q&As